Arthur M. Cohen & Associates, LLC Vir Biotechnology, Inc. Transaction History

Arthur M. Cohen & Associates, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 19, 2023	BUY	$23.2 - $27.29 $8,653 - $10,179	373 Added 4.06%	9,551 $234,000
Q4 2022 Jan 17, 2023	BUY	$19.96 - $28.22 $183,192 - $259,003	9,178 New	9,178 $0
Q2 2022 Jul 18, 2022	SELL	$19.08 - $26.7 $138,826 - $194,269	-7,276 Closed	0 $0
Q4 2021 Jan 24, 2022	BUY	$30.97 - $54.03 $63,519 - $110,815	2,051 Added 39.25%	7,276 $305,000
Q3 2021 Oct 08, 2021	BUY	$34.9 - $54.54 $182,352 - $284,971	5,225 New	5,225 $227,000

219

87.4M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $922M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Arthur M. Cohen & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on Arthur M. Cohen & Associates, LLC with notifications on news.